Skip to main content

Table 2 The maximum dosage of glucocorticoids required to achieve rapid remission in AOSD patients

From: Clinical phenotypes and prognostic factors of adult-onset Still’s disease: data from a large inpatient cohort

Glucocorticoids (mg/kg/day)

Total (n, %)

Systemic inflammation type (n, %)

Pure type (n, %)

Intermediate type (n, %)

P value

<0.5

27 (5.5)

6 (3.6)

12 (11.5)

9 (4.1)

0.0097

0.5–1.0

229 (46.7)

59 (34.9)

58 (55.8)

112 (51.6)

0.0006

>1.0

234 (47.6)

104 (61.5)

34 (32.7)

96 (44.2)

<0.0001

  1. AOSD Adult-onset Still’s disease